EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease

Eun Yeong Lim, Eun-Ji Song, Hee Soon Shin

Journal of Microbiology and Biotechnology · 28.09.2023 · 33 (9) · 1111-1118

DOI: 10.4014/jmb.2301.01033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 30.03.2023. Verfasst von Eun Yeong Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Food Functionality Research Division, Wanju-gun, Jeollabuk-do 55365, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Korea Food Research Institute, Korean Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a long-term condition that affects the airways and lungs, chronic obstructive pulmonary disease (COPD) is characterized by inflammation, emphysema, breathlessness, chronic cough, and sputum production. Currently, the bronchodilators and anti-inflammatory drugs prescribed for COPD are mostly off-target, warranting new disease management strategies. Accumulating research has revealed the gut-lung axis to be a bidirectional communication system. Cigarette smoke, a major exacerbating factor in COPD and lung inflammation, affects gut microbiota composition and diversity, causing gut microbiota dysbiosis, a condition that has recently been described in COPD patients and animal models. For this review, we focused on the gut-lung axis, which is influenced by gut microbial metabolites, bacterial translocation, and immune cell modulation. Further, we have summarized the findings of preclinical and clinical studies on the association between gut microbiota and COPD to provide a basis for using gut microbiota in therapeutic strategies against COPD. Our review also proposes that further research on probiotics, prebiotics, short-chain fatty acids, and fecal microbiota transplantation could assist therapeutic approaches targeting the gut microbiota to alleviate COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeProbioticsPulmonary Disease, Chronic ObstructiveAnimalsHumansPrebioticsInflammationDysbiosis

Stichwörter der Autor:innen

Gut microbiotachronic obstructive pulmonary diseasefecal microbiota transplantationprebioticsprobioticsshort-chain fatty acids

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Food Functionality Research Division, Wanju-gun, Jeollabuk-do 55365, Republic of Korea.
  • Department of Food Biotechnology, Korea University of Science and Technology, Daejeon 34113, Republic of Korea.

Förderung

  • Korea Food Research Institute
  • Korean Ministry of Science and ICT

Zitieren

APA

Lim, E. Y., Song, E. J., & Shin, H. S. (2023). Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease. Journal of Microbiology and Biotechnology, 33(9), 1111-1118. https://doi.org/10.4014/jmb.2301.01033

Vancouver

Lim EY, Song EJ, Shin HS. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease. Journal of Microbiology and Biotechnology. 2023;33(9):1111-1118. doi:10.4014/jmb.2301.01033

BibTeX
@article{Lim2023,
  author = {Lim, Eun Yeong and Song, Eun-Ji and Shin, Hee Soon},
  title = {Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2023},
  volume = {33},
  number = {9},
  pages = {1111--1118},
  doi = {10.4014/jmb.2301.01033}
}
Kostenlos starten →